This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2011 Jul 13;475(7355):S12-4.

doi: 10.1038/475S12a.

Amyloid: little proteins, big clues

PMID: 21760575
DOI: 10.1038/475S12a

Amyloid: little proteins, big clues

Jim Schnabel. Nature. 2011.

. 2011 Jul 13;475(7355):S12-4.

doi: 10.1038/475S12a.

Author

PMID: 21760575
DOI: 10.1038/475S12a

No abstract available

PubMed Disclaimer

Similar articles

Dynamics of plaque formation in Alzheimer's disease.
Urbanc B, Cruz L, Buldyrev SV, Havlin S, Irizarry MC, Stanley HE, Hyman BT. Urbanc B, et al. Biophys J. 1999 Mar;76(3):1330-4. doi: 10.1016/S0006-3495(99)77295-4. Biophys J. 1999. PMID: 10049316 Free PMC article.
Prion infection of mice transgenic for human APPSwe: increased accumulation of cortical formic acid extractable Abeta(1-42) and rapid scrapie disease development.
Baier M, Apelt J, Riemer C, Gültner S, Schwarz A, Bamme T, Burwinkel M, Schliebs R. Baier M, et al. Int J Dev Neurosci. 2008 Nov;26(7):821-4. doi: 10.1016/j.ijdevneu.2008.07.001. Epub 2008 Jul 9. Int J Dev Neurosci. 2008. PMID: 18662767
Medicine. Prion-like behavior of amyloid-beta.
Kim J, Holtzman DM. Kim J, et al. Science. 2010 Nov 12;330(6006):918-9. doi: 10.1126/science.1198314. Science. 2010. PMID: 21071652 No abstract available.
[Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
Asai M, Kawakubo T, Mori R, Iwata N. Asai M, et al. Yakugaku Zasshi. 2017;137(7):801-805. doi: 10.1248/yakushi.16-00236-2. Yakugaku Zasshi. 2017. PMID: 28674290 Review. Japanese.
Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases.
Díaz-Nido J, Wandosell F, Avila J. Díaz-Nido J, et al. Peptides. 2002 Jul;23(7):1323-32. doi: 10.1016/s0196-9781(02)00068-2. Peptides. 2002. PMID: 12128089 Review.

See all similar articles

Cited by

SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain.
Sillerud LO, Solberg NO, Chamberlain R, Orlando RA, Heidrich JE, Brown DC, Brady CI, Vander Jagt TA, Garwood M, Vander Jagt DL. Sillerud LO, et al. J Alzheimers Dis. 2013;34(2):349-65. doi: 10.3233/JAD-121171. J Alzheimers Dis. 2013. PMID: 23229079 Free PMC article.
Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
Viola KL, Klein WL. Viola KL, et al. Acta Neuropathol. 2015 Feb;129(2):183-206. doi: 10.1007/s00401-015-1386-3. Epub 2015 Jan 22. Acta Neuropathol. 2015. PMID: 25604547 Free PMC article. Review.
Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits.
Xu Z, Xiao N, Chen Y, Huang H, Marshall C, Gao J, Cai Z, Wu T, Hu G, Xiao M. Xu Z, et al. Mol Neurodegener. 2015 Nov 2;10:58. doi: 10.1186/s13024-015-0056-1. Mol Neurodegener. 2015. PMID: 26526066 Free PMC article.
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism.
Cohen SI, Linse S, Luheshi LM, Hellstrand E, White DA, Rajah L, Otzen DE, Vendruscolo M, Dobson CM, Knowles TP. Cohen SI, et al. Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9758-63. doi: 10.1073/pnas.1218402110. Epub 2013 May 23. Proc Natl Acad Sci U S A. 2013. PMID: 23703910 Free PMC article.
Assessing Reproducibility in Amyloid β Research: Impact of Aβ Sources on Experimental Outcomes.
Foley AR, Raskatov JA. Foley AR, et al. Chembiochem. 2020 Sep 1;21(17):2425-2430. doi: 10.1002/cbic.202000125. Epub 2020 May 5. Chembiochem. 2020. PMID: 32249510 Free PMC article.

See all "Cited by" articles

References

1. Science. 2010 Nov 12;330(6006):980-2 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information